Announcements Trials

Browse Landscape

Phase

Phase 2 11 Phase 3 4 Phase 1/2 3 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Completed 9 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Propofol 9 Sevoflurane 7 Rituximab 7 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Trastuzumab 5 Specimen Handling 5 Enoxaparin 5 Carboplatin 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 Bupivacaine 4 trametinib 3 pirtobrutinib 3 dabrafenib 3 atezolizumab 3 apixaban 3 Lenalidomide 3 Indocyanine Green 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 ribociclib 2 polyethylene glycol 3350 2 pertuzumab 2 pembrolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × pegfilgrastim × Clear all

NCT05753618 2026-02-09

REaCT-OGF

Ottawa Hospital Research Institute

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡